Literature DB >> 25854361

Association between ABO genotype and risk of hepatocellular carcinoma in Koreans.

Hyung-Jeong Shim1, Ran Lee, Min-Ho Shin, Hee-Nam Kim, Duck Cho, Hye-Ran Ahn, Sun-Seog Kweon.   

Abstract

BACKGROUND: Associations between ABO blood groups and risk of several malignancies have been reported, although there are limited data regarding hepatocellular carcinoma (HCC). The aim of this study was to investigate any possible association between the ABO genotype, especially blood group A, and HCC risk in Koreans.
MATERIALS AND METHODS: We conducted a case-control study of 1,538 patients with newly diagnosed HCC at Chonnam National University Hwasun Hospital and 1,305 randomly selected members of the general population. The ABO genotype was determined by multicolor real-time polymerase chain reaction (PCR) using displacing probes. Adjusted odds ratios (aORs) and their 95% confidence intervals (CIs) were calculated using logistic regression models with adjustment for gender, age, smoking, alcohol drinking, and hepatitis B and C status.
RESULTS: The risk of HCC in genotype AA was significantly higher than in OO (aOR=1.773, 95% CI=1.161-2.705). The risk in blood group A was also higher than in blood group O (aOR=1.448, 95% CI=1.005 1.897). No significant difference was found for the AA, BO, BB, and AB genotypes, or blood group B and AB.
CONCLUSIONS: Blood group A and genotype AA showed the highest risks of HCC in a Korean population. No significant difference was found for the AO, BO, BB, and AB genotypes, or blood group B and AB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854361     DOI: 10.7314/apjcp.2015.16.7.2771

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Rapid ABO genotyping by high-speed droplet allele-specific PCR using crude samples.

Authors:  Chiaki Taira; Kazuyuki Matsuda; Naoya Takeichi; Satomi Furukawa; Mitsutoshi Sugano; Takeshi Uehara; Nobuo Okumura; Takayuki Honda
Journal:  J Clin Lab Anal       Date:  2017-03-13       Impact factor: 2.352

2.  ABO blood groups and liver cancer: prospective results from an HBsAg cohort study.

Authors:  Ling-Ling Lu; Yong-Hui Zhang; Mei-Hua Yao; Jian-Hua Lu; Yong-Sheng Chen; Jun Xu; Jian Zhu; Hai-Zhen Chen; Jian-Guo Chen
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

3.  ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization.

Authors:  Kittipitch Bannangkoon; Keerati Hongsakul; Pimsiri Sripongpun; Apichat Kaewdech; Naichaya Chamroonkul; Teeravut Tubtawee; Teerha Piratvisuth
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

4.  ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy.

Authors:  Tao Wu; Xiao-An Ma; Guo-Qing Wang; Qing Li; Miao-Jing Li; Jin-Yue Guo; Xuan Liang; Zhi-Ping Ruan; Tao Tian; Ke-Jun Nan; Li-Na Liu; Hui Guo
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

5.  Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China.

Authors:  Xu Li; Hongqin Xu; Zhongyang Ding; Qinglong Jin; Pujun Gao
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.